{"ticker": {"uuid": "a4cef1c1-11e0-4bba-95ee-456c5e60f0c9", "symbol": "HYPE3", "name": "Hypera S.A.", "exchange": "SAO", "country": "BR", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Hypera outlines long-term growth strategy as a leading Brazilian pharma group", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPR21IRjQxbFNtbVAxMHVHVFQtQ3NGNTZRSnYxc0xIMWpyQ21XVk5IX2hXNk9UVks4b3NfRF9Sd3ZhanNBMHhvclBwQlhjdk1iWG9UNzJ2VHItVHJRZ1BHa2FsV3NYSUcyYW9FdGRNN2RvYm8zeEh3TnNRZW9nMjdJazQ4UkFOdlRyNUhBUDZaSV9wWm11a2IzaUNsWlB3UmROOURsSG9ReWl3Wk5sZXlENWJUQmJSWEtwODJsSzhueUg1djR4NHFyaEh3?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-05T07:00:00+00:00", "published_display": "05 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hypera S.A. 2026 Q1 - Results - Earnings Call Presentation (OTCMKTS:HYPMY) 2026-05-02", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPX1lNRWtjUDlUUElJSDkwQzdCNTNwbnRSZEZqLS12Sm85WHluaTVyMWFMUnFpVzMwM3BWSkJXbXJUNXdWOHZMM0ttMWlXNmVXZzdmcnlqZk1yd1RjNVc4eEt3Q0FkbV9XYkY3eDFCTmtMOGRaM3B2ZElrLUxZeG16dS1xU1JuX1l0bGVnNGlST0pyWGZLeUhJeTV3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How many employees work at Hypera?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE9LWlYtelpxRkVSNFN0MlZPcGczU2IzaEc0U0FybVRxOVNIUVY5NW5zamQ0eWp4c1JyOGhtNlJhcTRFQjZONWsxQlNmSnRoc2FLY2V4Sm1NYmM2VGROdmlFS0M2SDFmZw?oc=5", "source_name": "Revelio Labs", "published_at": "2026-04-09T11:36:38+00:00", "published_display": "09 Apr 2026 11:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hypera S A : Notice to Shareholders - Capital Increase", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNSVBEenVQZzFrTlFlVmN3MTZpYmJaZ1lpZVdyVWJYSllXckIwNXQyZHZKbk05SEh0VVVYNXNGLVJzN3dMSHJhaHNwVHNsN1lHN3l3eFpfUnRHMEtCSjRRV3JXQTNqbW9paE5iaDEtSlJpbG5vQlB2UTdvaGZmemY0UXRDanF2bFRUbUNxRkpUcDVncWdmTGpPRkhOSDl2TEVrQXphQUZR?oc=5", "source_name": "marketscreener.com", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brazil's Hypera to launch an Ozempic generic in 2026, CEO says", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOSjV4S25BUURPMVpHWlE0UkxrT3VXU0txT0xlc1N4NC1jVzNRR19WRVdBblU2WVRHVVRzWk9GYTlsREV3VUxzMGMxUUl2Vm5VTFdmeno5dUdBV3dvX0JlbkFrUmc0X1RRVExZOEs1c2Q2eldUdFZFUUpXWjczc01GNDdpbVBlbUN4aG9YMmhGTjVWNGRCVGNKNjI5bG5Fby1Td0lhNEZ6QktQR2RRLTZDWTJ6Z2ZHZUQ4RjBmUnEwMTZxc2Nt?oc=5", "source_name": "Reuters", "published_at": "2025-03-21T07:00:00+00:00", "published_display": "21 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Hypera outlines long-term growth strategy as a leading Brazilian pharma group", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPR21IRjQxbFNtbVAxMHVHVFQtQ3NGNTZRSnYxc0xIMWpyQ21XVk5IX2hXNk9UVks4b3NfRF9Sd3ZhanNBMHhvclBwQlhjdk1iWG9UNzJ2VHItVHJRZ1BHa2FsV3NYSUcyYW9FdGRNN2RvYm8zeEh3TnNRZW9nMjdJazQ4UkFOdlRyNUhBUDZaSV9wWm11a2IzaUNsWlB3UmROOURsSG9ReWl3Wk5sZXlENWJUQmJSWEtwODJsSzhueUg1djR4NHFyaEh3?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-05T07:00:00+00:00", "published_display": "05 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hypera S.A. 2026 Q1 - Results - Earnings Call Presentation (OTCMKTS:HYPMY) 2026-05-02", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPX1lNRWtjUDlUUElJSDkwQzdCNTNwbnRSZEZqLS12Sm85WHluaTVyMWFMUnFpVzMwM3BWSkJXbXJUNXdWOHZMM0ttMWlXNmVXZzdmcnlqZk1yd1RjNVc4eEt3Q0FkbV9XYkY3eDFCTmtMOGRaM3B2ZElrLUxZeG16dS1xU1JuX1l0bGVnNGlST0pyWGZLeUhJeTV3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How many employees work at Hypera?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE9LWlYtelpxRkVSNFN0MlZPcGczU2IzaEc0U0FybVRxOVNIUVY5NW5zamQ0eWp4c1JyOGhtNlJhcTRFQjZONWsxQlNmSnRoc2FLY2V4Sm1NYmM2VGROdmlFS0M2SDFmZw?oc=5", "source_name": "Revelio Labs", "published_at": "2026-04-09T11:36:38+00:00", "published_display": "09 Apr 2026 11:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hypera S A : Notice to Shareholders - Capital Increase", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNSVBEenVQZzFrTlFlVmN3MTZpYmJaZ1lpZVdyVWJYSllXckIwNXQyZHZKbk05SEh0VVVYNXNGLVJzN3dMSHJhaHNwVHNsN1lHN3l3eFpfUnRHMEtCSjRRV3JXQTNqbW9paE5iaDEtSlJpbG5vQlB2UTdvaGZmemY0UXRDanF2bFRUbUNxRkpUcDVncWdmTGpPRkhOSDl2TEVrQXphQUZR?oc=5", "source_name": "marketscreener.com", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brazil's Hypera to launch an Ozempic generic in 2026, CEO says", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOSjV4S25BUURPMVpHWlE0UkxrT3VXU0txT0xlc1N4NC1jVzNRR19WRVdBblU2WVRHVVRzWk9GYTlsREV3VUxzMGMxUUl2Vm5VTFdmeno5dUdBV3dvX0JlbkFrUmc0X1RRVExZOEs1c2Q2eldUdFZFUUpXWjczc01GNDdpbVBlbUN4aG9YMmhGTjVWNGRCVGNKNjI5bG5Fby1Td0lhNEZ6QktQR2RRLTZDWTJ6Z2ZHZUQ4RjBmUnEwMTZxc2Nt?oc=5", "source_name": "Reuters", "published_at": "2025-03-21T07:00:00+00:00", "published_display": "21 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 46, "total_relevant": 5, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 4, "score": 53, "total": 5, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 73, "events": [{"event": "general", "label": "Market update", "weight": 2.55, "count": 4}, {"event": "earnings", "label": "Earnings", "weight": 0.9, "count": 1}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 21.11, "latest_week": "2026-07-10", "one_week_move": 0.6, "four_week_move": -0.6, "twelve_week_move": -10.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.002728, "market_dynamics_buy_signal": false, "relative_strength": -16.234696, "fair_value_gap": -15.8, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 47.0944, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.6% over one week, -0.6% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 49, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "ad-hoc-news.de", "count": 1}, {"label": "Seeking Alpha", "count": 1}, {"label": "Revelio Labs", "count": 1}, {"label": "marketscreener.com", "count": 1}, {"label": "Reuters", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 5}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 4}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "73/100 classification confidence."}, {"label": "Company focus", "value": "5", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.6% over one week, -0.6% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Hypera outlines long-term growth strategy as a leading Brazilian pharma group"}], "updated_at": "2026-07-17T20:41:26.025534+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}